-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 1
Acknowledgements: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation